{"symbol":"BSX","fiscalQuarter":"Q2-2016","reportDate":"2016-07-28","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q2-2016","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Up 2.87%","keyNumbers":[{"metric":"EPS","actual":"$0.27","expected":"N/A","surprise":"+1.89%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our earnings performance this quarter.","Our focus remains on innovation and expanding our market presence."],"summary":"Management expressed satisfaction with the earnings results, highlighting their commitment to innovation. They emphasized their strategy to enhance market share."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report shows a positive surprise in EPS, which contributed to a 2.87% increase in stock price. The management's cautious optimism suggests they are focused on maintaining growth through innovation. However, the lack of revenue data and guidance leaves some uncertainty about future performance.","metaDescription":"Boston Scientific (BSX) Q2 2016 earnings: EPS beat by 1.89%. Stock up 2.87%. Full breakdown."}}